Endoglin is a cell-surface adhesion protein as well as a coreceptor for transforming growth factor-b (TGF-b). It is located on endothelial and few other cells, but also found on certain tumor cells. Brain metastatic breast tumor cells derived from the MDA-MB-231 cell line heavily express endoglin in contrast to the corresponding parental ones. To clarify whether this determines their invasive phenotype, we compared their biological properties with endoglin-silenced brain-metastatic cells, lowexpressing parental cells and these transfected with L-and S-endoglins, isoforms transducing or lacking TGF-b signals. All L-endoglin-overexpressing cells were characterized by numerous invadopodia where endoglin was preferentially localized. Endoglin-expression resulted in elevated levels of the matrix metalloproteinases (MMP-1 and MMP-19) and downregulation of the plasminogen activator inhibitor-1. In Boyden-chamber and woundhealing assays, endoglin-overexpressing cells showed a considerably higher migration and chemotaxis to TGF-b. In 3D spheroid confrontation assays between breast tumor cells and TGF-b-secreting glioma cells, high L-endoglinexpressing cells invaded into the glioma-spheroids whereas low-endoglin-expressing cells dissociated in the culture; invasion was blocked by TGF-b antibodies. In contrast to parental cells, endoglin-overexpressing cells invaded deeply into mouse brain slices. Thus, endoglin expression on tumor cells enhances their invasive character by formation of invadopodia, extracellular proteolysis, chemotaxis and migration.
Introduction
Metastases are the major source of morbidity and mortality in cancer patients. Breast cancer frequently metastasizes into bone, lung, liver and brain where it is the second important metastatic cancer . Despite this clinical importance, little is known about genes necessary for cancer metastasis into distinct tissues, especially, into the brain with its unique microenvironment (Weil et al., 2005; Steeg, 2006) . Metastasis requires the dissemination of malignant cells from tumor tissue, transport in blood/lymphatic vessels, invasion and homing in target tissues (Fidler, 2003; Steeg, 2006) . For invasion and homing, metastatic tumor cells need a higher mobility, higher protease activities as well as an altered expression of adhesion molecules.
Recently, we obtained selectively brain (MDA-Br)-and bone (MDA-Bo)-seeking clones from MDA-MB-231 human invasive breast cancer cells (Yoneda et al., 2001) after several passages in mice. Examination of mRNA and protein expression showed several differentially expressed genes, among them a lower expression of Kiss1 (metastin), higher expressions of some matrix metalloproteinases (MMP1 and MMP9; Stark et al., 2007) and especially of endoglin.
Endoglin (CD105) is a disulfide-linked homodimeric cell membrane glycoprotein of 180 kDa that is strongly expressed on endothelial cells, in particular on tumor vasculature, and weakly on few other cell types including macrophages, fibroblasts, syncytiotrophoblasts (Fonsatti et al., 2003) . It functions as an adhesion molecule for integrins and/or other RGD ligands, but acts also as accessory component of the transforming growth factor-b (TGF-b) receptor complex (Fonsatti et al., 2001) . Defects in the endoglin gene cause hereditary hemorrhagic telangiectasia type 1 (or OslerRendu-Weber syndrome 1), an autosomal dominant multisystemic vascular dysplasia, demonstrating that endoglin exerts a crucial role in vascular development and angiogenesis. Two different isoforms, L-and Sendoglins differing in the amino-acid composition of their cytoplasmic tails have been characterized (Gougos and Letarte, 1990) . The predominant isoform L-endoglin contains 47 residues in the cytoplasmic domain, whereas S-endoglin has only 14 amino acids and lacks TGF-b signal transduction (Lastres et al., 1994) .
In solid tumors, endoglin is found on endothelial cells of peri-and intratumoral blood vessels and on stromal components, but also on tumor cells, especially on human sarcoma, carcinoma, metastatic melanoma and breast tumor cells (Fonsatti et al., 2001; Postiglione et al., 2005) . In the light of these reports and our findings, we evaluated the role of endoglin in tumor invasion by comparing the biological properties of brain-metastatic MDA-MB-231 breast tumor cells, their corresponding endoglin-silenced cells, parental cells as well as L-and S-endoglin-overexpressing parental cells. We found that high endoglin expression changes cellsurface morphology by formation of invadopodia-like structures, elevates proteases degrading extracellular matrix and reduces protease inhibitors, increases migration, chemotaxis and invasion into brain microenvironment.
Results
Endoglin is constitutively overexpressed in metastatic breast tumor cells Endoglin expression in parental (MDA-Pa) and brain/ bone metastatic (MDA-Br and MDA-Bo) breast tumor cells was analysed by quantitative reverse transcription (RT)-PCR, western blot and immunocytochemistry (Figures 1 and 2 ). All methods indicated massive higher expression of endoglin in metastatic cells on the mRNA (Figure 1a ) and protein levels (Figures 1d and 2) . By quantitative RT-PCR a more than 140-fold higher endoglin expression was measured in brain metastatic breast tumor cells as compared to that in parental cells (Figure 1a ). It reached similar magnitudes as in endothelial cells and a monocyte cell line that served as positive controls. In contrast, endoglin in MDA-MB-231 parental breast tumor cells was as low as in other types of tumor cells; for example, glioma cells ( Figure 1a ). These differences in endoglin expression remained stable during all subcultures or changing to serum-free conditions.
Higher endoglin expression was also detected in T47-D and BT549 breast cancer cells that are known to metastasize into the brain, but not in MC-F7 cells (Figure 1c ).
Overexpression and silencing of endoglin as tools to study the biological role of endoglin in tumor biology As further tools to investigate the biological importance of endoglin for tumor cell biology, we overexpressed endoglin in parental MDA cells and knocked-down endoglin in brain metastatic MDA cells by short hairpin RNA (shRNA), both by stable transfection. Overexpression was achieved with L-and S-endoglin vectors which are distinguished by the length of the resulting cytoplasmic domain in the expressed proteins. Hereby, S-endoglin lacks TGF-b-signal-transducing activity associated with L-endoglin.
In several clones, endoglin expression rates on the mRNA and protein levels reached those in the metastatic cells (or cultivated endothelial cells, Figures 1b, d and 2). Two of the clones (MDA-Pa-L-End and -S-End) were subsequently used to elucidate the influence of endoglin expression (L-and S-type) in tumor cells without change of other molecules (as in the metastatic cells). As opposite tool, endoglin expression was knocked-down by shRNA to about one-fifth in the metastatic brain MDA cells (MDA-Br-si) allowing functional studies with endoglin reduction in a highexpressing cell. For some experiments also additional independent clones were used, their endoglin overexpression/silencing are given in Figure 1b .
Endoglin is localized on invadopodia By light microscopic immunocytochemistry (Figure 2 top), endoglin was detected in high-expressing cells, either naturally generated or transfected (MDA-Br and MDA-PA-L-End), whereas low-expressing cells (MDAPa and MDA-Br-si) showed almost no or lower staining. Morphologically, the brain metastatic cells (MDA-Br) were a bit larger than the parental cells (MDA-Pa). L-Endoglin-overexpressing cells were characterized by numerous invadopodia extending from the cells, whereas the low-expressing parental cells showed a relatively smooth cell surface in light and electron microscopy ( Figure 2 , top and middle).
By immunoelectron microscopy ( Figure 2 , bottom, post-embedding staining), endoglin was frequently found on the invadopodia of overexpressing cells (MDA-PA-L-End and-not shown-MDA-Br); however, endoglin was also detected on the cell surface and in intracellular structures. In contrast, endoglin could hardly be visualized in low-expressing cells.
Endoglin overexpression is associated with higher expression of matrix proteases and lower expression of protease inhibitors Since matrix-degrading proteases/inhibitors are indispensable for metastatic tumor cell invasion, we investigated the influence of endoglin (over) expression by quantitative RT-PCR and western blots. Of the matrix metalloproteinases tested, MMP-1 and MMP-19 were considerably upregulated in the brain metastatic MDA-cells and the endoglin-overexpressing parental cells (Figures 3a and b) . Certain differences between these cell types indicate that endoglin might be not the only factor regulating MMP-expression. The matrixdegrading serine protease urokinase-type PA (uPA) was highly expressed in all tested MDA-MB-231 cell lines; their DC T for mRNA-expression varied only moderately (values in the range of 3.7-4.7).
However, the secreted inhibitor of uPA, plasminogen activator inhibitor-1 (PAI-1), was considerably downregulated in brain metastatic and L-endoglin-overexpressing cells at the cellular mRNA and extracellular (secreted) protein level (Figures 3c and d) . In contrast, parental and the S-endoglin-overexpressing cells show a comparable high mRNA and (secreted) protein expression. The differences between L-and S-endoglinoverexpression indicated that an inhibitory effect of TGF-b signal transduction should be responsible for the downregulation of PAI-1.
Endoglin overexpression increases chemotaxis, invasion and attachment of breast tumor cells to brain cells/tissue
The previous results on endoglin localization on invadopodia and its role in regulating matrix proteases already suggest that endoglin overexpression may be implicated in tumor cell invasion, one hallmark of tumor metastasis. Therefore, we investigated effects of endoglin overexpression and TGF-b-stimulation on migration, invasion and brain homing.
The influence of endoglin on breast tumor cell motility was investigated in wound healing assay ( Figure 4a ). Here, high endoglin-expressing cells, namely MDA-Pa-L-End and MDA-Br, easily migrated into an open space (scratch in the confluent cell layer) and filled it within 3 h. In contrast, the low-endoglinexpressing cells showed only a low-migratory potency; the scratch was only narrowed.
The dependency of chemotactic invasion from endoglin expression was measured with a Boyden-chamber assay ( Figure 4b ). Cells migrated through membranes with 5 mm pores covered with matrigel (mixture of proteins from basal membranes) to a lower chamber filled with or without 5 ng ml À1 TGF-b. Basal migration after 3 h differed somewhat between the MDA cells, To verify this in a 3D model and to mimic a brain environment, a confrontation assay of two colored spheroids (aggregates) from different MDA cells (green) and human glioma cells (red) was performed ( Figure 5a ). Glioma cells and also the cell line U343 produce huge amounts of TGF-b (Held-Feindt et al., 2003) , show low-endoglin content ( Figure 1a ) and provide brain extracellular matrix proteins. The spheroids of gliomas cells formed under cultivation with methylcellulose remained stable over 48 h in standard medium whereas MDA spheroids partly dissociated under the confrontation conditions. MDA-Pa cells were not attracted by the U343 glioma cells, and they remained either in their aggregates or dispersed irregularly. In contrast, MDA-Br cells were massively attracted from U343 cells, MDA-Br spheroids completely vanished, the MDA-Br cells infiltrated into U343 spheroids and were found in clusters or intermingled with the U343 cells. The endoglin-overexpressing MDA-Pa-L-End cells showed a similar behavior as the MDA-Br cells. In contrast to the L-endoglin-overexpressing cells, MDA-Pa, MDA-S-End or MDA-Br-si cells never invaded the U343 spheroids, although remains of MDA-S-End spheroids were occasionally attached to the surface of U343 aggregates (Figure 5a) .
To identify the factor(s) responsible for chemotaxis and invasion, the experiments were repeated under addition of TGF-b-neutralizing antibodies (Figure 5a) . Here, neither MDA-Pa-L-End nor MDA-Br cells showed any attachment or invasion into U343 spheroids. Instead, their spheroids dissociated completely. These experiments show that only L-endoglinoverexpressing breast tumor cells are attracted by Using freshly prepared mouse brain slices, we next investigated whether invasion and homing in brain is endoglin dependent. For this, MDA-parental and L-endoglin-overexpressing cells were fluorescently labeled red or green, cultivated to spheroids and the spheroids carefully applied onto the surface of brain sections. After 24 h cultivation, only the green-fluorescent L-endoglin-overexpressing MDA cells were still attached on the brain section and, moreover, had invaded deeply into the brain slice (Figure 5b ). In contrast, the red-fluorescent MDA-parental cells detached from the brain tissue surface.
These experiments show that endoglin overexpression in tumor cells, either by transfection or by physiological selection, enhances their migration, their TGF-b-induced chemotaxis/invasion through matrigel, their TGF-b-induced invasion and incorporation into a 3D brain glial cell network as well as their invasion and homing in intact brain parenchyma.
Discussion
Metastasis is a multistep process involving proliferation of tumor cells, detachment, transport in the blood or lymph, adherence to vessels and tissues, intrusion into the host tissue, colonization, growth in the new micromilieu and subsequent angiogenesis (Fidler, 2003; Steeg, 2006) . Invasion occurs at several stages of metastasis, in the growth of the primary tumor, transport through barriers, extravasation and finally in the host tissue. This requires extracellular or basal membrane matrix degradation, adhesion and changes in the cytoskeleton as well as at the cell surface (Friedl and Wolf, 2003) . In our study, we show that endoglin expression in breast tumor cells augments their invasive phenotype at several steps: changing the cell-surface morphology, acting as a coreceptor for TGF-b-signaling and thereby regulating gene expression, for example, of proteases/inhibitors. Overall, chemotactic migration, invasion through basal lamina (matrigel) and into brain tissues/cells were considerably enhanced in endoglin-expressing tumor cells. À1 transforming growth factor-b1 after 6 h (western blots of lysates of serum-free cultivated cells; glyceraldehyde-3-phosphate dehydrogenase (GAPDH) serves as control for equal loading).
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Invadopodia are small punctate finger-like projections from the cell surface that extend into the matrix (Weaver, 2006) . They are found in invasive cancer cells where they perform adhesion and extracellular matrix degradation. Invadopodia-associated transmembrane proteases include MT1-MMP (membrane-type1 MMP ¼ MMP14) that activates other MMPs, the serine proteases seprase (fibroblast activation protein-a (FAPa)) and metalloproteinases of the ADAM's family (Weaver, 2006) . In accordance, invadopodia formation in breast cancer cell lines correlates with enhanced movements through matrigel-coated transwell filters as well as with metastasis in nude mouse models (Bowden et al., 1999) . Hypoxia is known to increase invadopodia formation and invadopodia localization of MT1-MMP (Mun˜oz-Na´jar et al., 2006) . Here, we show that endoglin expression is also associated with the formation of invadopodia. It could be well understood that the invasion-/invadopodia-related complex of extracellular proteases and intracellular src kinase/src-associated proteins and small GTPases is stabilized or also includes endoglin.
Besides the correlation of endoglin expression and invadopodia formation, endoglin regulates the gene expression of several matrix-degrading proteases and inhibitors. MMP-1 and MMP-19 are upregulated; PAI-1 is downregulated. This regulation is at least partly dependent from TGF-b for which L-endoglin is an important coreceptor. Since TGF-b is abundantly released from platelets, endoglin-overexpressing cells are stimulated under serum-containing conditions. MMP-1 (interstitial collagenase) cleaves different collagen types (I, II, III, VII and X). Its expression is induced by growth factors, such as epidermal growth factor (EGF) and by proinflammatory cytokines, such as tumor necrosis factor-a or interleukin-1. MMP-1 is synthesized as a preproenzyme of 469 amino acids and requires proteolytic processing to the active secreted form. This activation is accomplished by extracellular or by cell-surface proteases, such as other MMPs, uPA or MT-MMP-1. In breast cancer cells, MMP-1 is generally associated with a high invasive potential (Kousidou et al., 2004) . MMP-19 (formerly known as MMP-18) cleaves components of the basal lamina, such as collagen type IV, laminin-5, nidogen (entactin), but also extracellular matrix proteins, such as tenascin, aggrecan, fibronectin (Beck et al., 2007) . In the normal resting mammary gland, MMP-19 is strongly expressed in the myoepithelial layer of the ductal system, in the smooth muscle and endothelial layers of blood vessels, lesser in the alveolar and ductal epithelia. In breast tumors, MMP-19 rises and declines in malignant cells, but expression seem to be strongly influenced by the surrounding extracellular matrix (Djonov et al., 2001) . MMP-19 in metastatic breast tumor cells has not yet been reported. PAI-1 is a secreted inhibitor of serine proteases, such as tissue-type PA or uPA which are implicated not only in fibrinolysis, but also in tissue remodeling, angiogenesis and tumor invasion. It is well known that high levels of uPA in human tumors are associated with a poor patient prognosis; however, PAI-1 has a more complicated role in tumor progression than simply counteracting uPA (Mazar et al., 1999) . Taking together, endoglin-overexpression changes the proteolytic balance of the cells to higher matrix degradation Endoglin enhances tumor invasion D Oxmann et al factor/chemokine receptors, for example, of Her-2/ EGFR (Palmieri et al., 2007) or CX3CR1 (Andre et al., 2006) .
Material and methods

Cell culture and transfections
Breast cancer cells were cultivated in Dulbecco's modified Eagle's medium (DMEM), supplemented with 10% fetal calf serum (FCS) ) and other cells as described (Ludwig et al., 2005) . Plasmids carrying L-or S-endoglincDNA as well as endoglin-shRNA-vector pSUPER-EndoEX4 were kindly provided by Dr Carmelo Bernabeu (Madrid, Spain). Endoglin-cDNAs were subcloned from selectionmarker-free pcEXV vectors in the EcoRI site of pcDNA3.1/ Zeo (Invitrogen, Carlsbad, CA, USA); the endoglin-shRNA vector was equipped with a SalI-fragment comprising the Zeocin resistance cassette of pSUPER-Zeo. Ligation products were verified by sequencing.
Transfections were performed using Lipofectin transfection reagent (Invitrogen) on cells cultivated to 70% confluency. For stable clones, cells were transfected with 17 mg vector and 34 ml Lipofectin. After Zeocin selection for 2 weeks, single colonies were trypsinized, expanded in separate culture flasks and checked for modified endoglin expression.
Quantitative RT-PCR RNA was isolated with the TRIZOL reagent, digested by DNase and cDNA synthesized; quantitative RT-PCR was performed (Ludwig et al., 2005) in three replicates using TaqMan primer probes (Applied Biosystems, Foster City, CA, USA):
hGAPDH, Hs99999905_m1, GGGCGCCTGGTCACCA GGGCTGCTT; hEndoglin, Hs00164438_m1, TCCCAACGGGCCCGTCAC AGCTGGA; hMMP-1, Hs00233958_m1, AAAGACAGATTCTACAT GCGCACAA; hMMP19, Hs00275699_m1, GGATCCAGGCTCTCTAT GGCAAGAA; hPAI-1, Hs00167155_m1, GATTCAAGATTGATGACAA GGGCAT;
Cycle of threshold (C T ) was averaged, and DC T values ¼ C T Gene of interest-C T GAPDH calculated. For each gene, logarithmic linear dependence of C T values from the numbers of copies was verified by using different amounts of cDNA; one magnitude yielded a DC T of 3.33 (2 3.33 ¼ 10).
Immunocytochemistry and immunoelectron microscopy For light microscopy, cells grown on poly-D-lysine-coated coverslips for 2 days were fixed with À20 1C cold acetone, immunostained with anti-endoglin (1:250 in phosphate-buffered saline (PBS), rabbit polyclonal antibody; Santa Cruz Biotechnology, Santa Cruz, CA, USA, sc-20632) and nuclei counterstained with hemalaun (Mentlein et al., 2004 
Invasion and migration assays
Chemotactic invasion were performed in 48-well Boydenchambers (Neuro Probe, Baltimore, MD, USA) using matrigel-coated polycarbonate membranes with 5 mm pores (Forstreuter et al., 2002) . For scratch assays, cells were cultured to confluence, scratched with a pipette tip and wound healing was continuously monitored under fresh medium with 10% FCS by video camera under a microscope at 37 1C and with CO 2 (7%). For quantitative evaluation, randomly selected areas of the scratch were analysed at the beginning and at different times for areas with invaded cells and normalized for the original open area according to: normalized area ¼ (area at 0 hÀarea at 10 h)/area at 0 h Â 100. For spheroid confrontation/invasion (Hattermann et al., submitted), spheroids of green fluorescent-labeled MDA cells were confronted to spheroids formed from red fluorescentlabeled human U343 glioma cells. Cultivated cells (2 Â 10 7 each) were incubated separately with either Cell Tracker Green or Cell Tracker Red (1:1000 in PBS from solutions of 0.5 mg (5(6)carboxyfluorescein diacetate succinimidyl ester or SNARF-1 in 80 ml dimethyl sulfoxide; Invitrogen) for 10 min. Cells were washed dye free, cultivated for 12 h, detached by trypsin treatment, suspended in 0.24% methylcellulose in DMEM with 10% FCS and 100 ml seeded into 96-well culture plate with conical wells. Different spheroids formed within 2-3 days were then transferred onto a poly-Dlysine-coated cover slip, and continued for 24 h with or without anti-TGF-b (rabbit polyclonal, R&D Systems). Confrontations were visualized after fixation with ice-cold acetone/methanol (1:1) for 10 min, washing in PBS (3 Â ), embedding in fluorescent mounting medium (Dako) and viewing under an Axiophot fluorescence microscope (Zeiss, Oberkochen, Germany).
Brain tissue invasion experiments were performed by application of spheroids from fluorescently labeled MDA cells on brain slice cultures (Stoppini et al., 1991) . Brains taken from 8 weeks old C57 mice were cut into 750-mm-thick slices using a chopper that were transferred onto culture inserts (0.4 mm Millicell-CM, Millipore) placed in wells of a 6-well cell culture plate; each well-contained 0.5 ml of DMEM plus glutamine. Then, spheroids of green-labeled MDA-L-End cells or red-labeled MDA-Pa cells were applied along with 10 ml of media onto the slices. After 24 h of cultivation in an incubator (37 1C, 10% CO 2 ), slices were washed with PBS and fixed with ice-cold acetone/methanol (1:1). After dehydration in series of 20-70% ethanol (20 and 70%, each for 2 min), slices were soaked for 10 min in a solution of Sudan Black to reduce background fluorescence. Subsequently, samples were washed, rehydrated (70%, followed by 20% ethanol and finally PBS), desalted in distilled water, embedded and examined as above. 
